Most of us have experienced the benefits of having strong and positive social relationships. We also know that a lack of these can lead to social isolation and loneliness – which are connected to illness and early death.
We know less about how social connections can influence our use of preventive health care services, such as screening, flu immunisation or health checks. Is it the quality of our relationships that matters, or how wide our networks are, or how often we are in contact with other people?
Our latest BITE – a postcard “need to know” summary of our published research – presents the findings of our investigation into whether and how social connections affect the use of recommended preventive health service programmes amongst people in their late 60s.
While it is common to target public health initiatives based on where people live or their economic and physical health circumstances, our work suggests using social connectedness indicators may also improve targeting of initiatives to increase preventive healthcare participation.
In addition, our results highlight the value of public health initiatives to increase social networks – itself a benefit beyond improving the uptake of services.
Mental Health in Emergency Departments: variations in service and care quality in England
How effective was a programme to improve NHS orthopaedic care in England? Evaluating Getting it Right First Time (GIRFT)
NHS 111/Urgent Care Patient Relationship Manager Evaluation
Using MRI perfusion images to stratify brain tumours
Application of multi-state models to prostate cancer screening
Social Care Prevention
Exploring decision-making processes and knowledge requirements in public health
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: A feasibility study for a randomised, blinded placebo-controlled trial (OMAhA)
Effectiveness and acceptability of myo-inositiol nutritional supplement in the prevention of gestational diabetes: a pilot placebo-controlled double-blind randomised trial (EMmY)
Prevention of progression to type 2 diabetes in women with gestational diabetes: A feasibility study for randomised trial on a Mediterranean diet
Improving the healthcare response to domestic violence (IRIS)
Improving the identification and management of people with HIV (RHIVA)
Impact and experiences of delayed discharge: A mixed studies systematic review
Linking health and local government data at household level to understand social determinants of health
Patient Research Ambassadors needed to promote health research from a patient point of view
We have teamed up with colleagues at the NIHR Clinical Research Network (CRN) to support their Patient Research Ambassador (PRA) initiative.
The Network is looking for patients, carers, and members of the public who have taken part in research and who are passionate about it.
The Ambassadors will help improve how local people across the North Thames patch find out about and participate in clinical research and also help to increase awareness of the importance of supporting clinical research. The PRAs will play their part in ensuring research is patient and public focussed.
Examples of the type of work PRAs do are below –
Full training and support will be available. As well as a chance to learn new skills and improve how research is planned and carried out in your area you will be part of a network of PRAs.
To find out more contact CRN North Thames patient and public involvement manager Christine Menzies by emailing email@example.com or calling 0207 679 9763
CLAHRC researcher Professor Jonathan Grigg is among leading doctors, public health professionals and organizations launching a new global advocacy group to mobilize clinicians and public health professionals to advocate for clean air policies.
Professor of Paediatric Respiratory and Environmental Medicine at Queen Mary University of London, Jonathan (below) is a leading UK paediatrician in the effects of air pollution. He is a founder member of the new interbational coalition, following his involvement in the UK based Doctors against Dieselinitiative.
According to the new group nine in ten people breathe polluted air, making it the world’s leading environmental cause of death and disease. Inspire aims to bring air pollution to the forefront of health and climate agendas.
It will offer a framework to push governments to address the root causes of air pollution and advocate for clean air policies and it aligns WHO’s road map for global action, including:
Improve awareness in the global health community about air pollution and its health effects
Increase involvement of clinicians and clinical organizations in advocacy for clean air policies
Establish a global network of informed health-oriented champions
Grow public awareness of the dangers of air pollution
Exert political pressure on governments to encourage aggressive clean air policies
A major new paper in the Lancet highlights rates of premature mortality that are two times higher in the most deprived areas of England (Blackpool) compared to most affluent (Wokingham).
Dr Harry Rutter, Clinical Research Fellow at the London School of Hygiene and Tropical Medicine was among the prominent experts in the field who authored the paper.
Dr Rutter, a public health physician, was Principal Investigator of the CLAHRC’s evaluation of the Greater London Authority’s Healthy Schools London programme.
The work presents findings from a new Global Burden of Disease (GBD) Study funded by the Bill & Melinda Gates Foundation and Public Health England.
The Global Burden of Disease includes evidence collected and analyzed by a consortium of more than 3,000 researchers in more than 130 countries and provides a tool for goverments and policy makers to measure health loss from hundreds of diseases, injuries, and risk factors, so that health systems can be improved and inequalties tackled
The authors of the Lancet paper used the data to estimate years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and attributable risks from 1990 to 2016 for England, Scotland, Wales, Northern Ireland, the UK, and 150 English Upper-Tier Local Authorities. They estimated the burden of disease by cause of death, condition, year, and sex.
You can view via an interactive ‘Lost Years’ map – which reveals the extent of health inequality across the UK.
Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Nicholas Steel, John A Ford, John N Newton, Adrian C J Davis, Theo Vos, Mohsen Naghavi, Scott Glenn, Andrew Hughes, Alice M Dalton, Diane Stockton, Ciaran Humphreys, Mary Dallat, Jürgen Schmidt, Julian Flowers, Sebastian Fox, Ibrahim Abubakar, Robert W Aldridge,Allan Baker, Carol Brayne, Traolach Brugha, Simon Capewell, Josip Car, Cyrus Cooper, Majid Ezzati, Justine Fitzpatrick, Felix Greaves, Roderick Hay, Simon Hay, Frank Kee, Heidi J Larson, Ronan A Lyons, Azeem Majeed, Martin McKee, Salman Rawaf, Harry Rutter, Sonia Saxena, Aziz Sheikh, Liam Smeeth, Russell M Viner, Stein Emil Vollset, Hywel C Williams, Charles Wolfe, Anthony Woolf, Christopher J L Murray
Black elders dismiss the warning signs of dementia until the condition becomes too severe to ignore or a crisis strikes. They are also less likely to receive a diagnosis of their condition, resulting in delayed treatment and less time to plan for the future.
Our latest BITE – a summary of published CLAHRC research provides an overview of our work with black elders, their families and carers to;
identify barriers and facilitators to seeking help for dementia.
based on what we found, work with dementia patients and their carers, volunteers from the public, clinicians and experts in the treatment and research of dementia to develop an intervention – a leaflet entitled Getting help for forgetfulness (below)
trial the intervention with GP registered patients, who were asked to rate it and evaluate its effect on their intention to seek help from their doctor.
The concept of knowledge co-production is used in health services research to describe partnerships (which can involve researchers, practitioners, managers, commissioners or service users) with the purpose of creating, sharing and negotiating different knowledge types used to make improvements in health services.
The CLAHRC has researchers “embedded” in a number of our partner organisations in the NHS and local government. The “researcher in residence” model has the advantage of allowing academics to be close to the ground and gain insight into how an organisation really operates. It also presents challenges in creating and maintaining key relationships and professional independence.
In a newly published BITE-sized summary of our research we present the results of our examination of three case studies and the wider implications for this model of working.
One to one nursing, or specialling is a way of caring for patients by providing continuous observation (by “sitters”) for an individual for a period of time during acute physical or mental illness.
Some patients need more than a general level of observation on a ward, often with the primary aim of reducing risk and protecting the patient.
Our review, published in a BITE, examined published evidence on the topic of specialling and sitters, aiming to identify the challenges and concerns relating to the cost effectiveness and quality of care.
Preventer inhalers (inhaled corticosteroids) are a common medication for asthma, and people get the full benefit of the medication by taking their prescribed doses correctly. We know many patients struggle to take enough doses effectvely, which impacts their ability to manage the condition.
Could pharmacists hold the key to helping patients take medicines effectively and in the right doses?
Our latest BITE – a postcard “need to know” summary of our research – presents the findings of our review of the evidence on whether pharmacists involved in asthma care could help people take their preventer inhaler as prescribed, therefore giving them the full benefit of their medication.
NIHR CLAHRC North Thames conducts ground-breaking research that directly impacts the health of patients with long term conditions and the health of the public.